Farms.com Home   News

Minister Bibeau announces appointments to the Canadian Grain Commission

Ottawa, Ontario – Minister of Agriculture and Agri-Food Marie-Claude Bibeau, announced the appointment of Doug Chorney as Chief Commissioner and Patty Rosher as Assistant Chief Commissioner of the Canadian Grain Commission. 
 
Doug Chorney has been an active player in the grain industry for 24 years, and was appointed Assistant Chief Commissioner of the Canadian Grain Commission in 2017. He has been the acting Chief Commissioner since June 2020. The term for his appointment is three years, effective immediately.
 
Patty Rosher has held various leadership and advisory positions over her 25-year career in the agriculture sector, most recently as General Manager of the Keystone Agricultural Producers. The term of her appointment is four years, effective February 15, 2021.
 
In 2016, the Government of Canada implemented an appointment process that is transparent and merit-based, to search for Canadians who reflect public sector values of respect for democracy, people, integrity, stewardship, and excellence.
Source : Government of Canada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.